386 related articles for article (PubMed ID: 26927085)
1. RNA Interference in the Age of CRISPR: Will CRISPR Interfere with RNAi?
Unniyampurath U; Pilankatta R; Krishnan MN
Int J Mol Sci; 2016 Feb; 17(3):291. PubMed ID: 26927085
[TBL] [Abstract][Full Text] [Related]
2. Controlling CRISPR-Cas9 by guide RNA engineering.
Hu LF; Li YX; Wang JZ; Zhao YT; Wang Y
Wiley Interdiscip Rev RNA; 2023 Jan; 14(1):e1731. PubMed ID: 35393779
[TBL] [Abstract][Full Text] [Related]
3. Simplified and effective RNA interference and CRISPR-Cas9 systems for Cryptococcus neoformans.
Chen Q; An B; Peng X; Wu Y; Peng M; Zhang C; He Y; Sang H; Kong Q
J Basic Microbiol; 2023 Oct; 63(10):1095-1105. PubMed ID: 37309240
[TBL] [Abstract][Full Text] [Related]
4. RNAi screening comes of age: improved techniques and complementary approaches.
Mohr SE; Smith JA; Shamu CE; Neumüller RA; Perrimon N
Nat Rev Mol Cell Biol; 2014 Sep; 15(9):591-600. PubMed ID: 25145850
[TBL] [Abstract][Full Text] [Related]
5. High-throughput functional genomics using CRISPR-Cas9.
Shalem O; Sanjana NE; Zhang F
Nat Rev Genet; 2015 May; 16(5):299-311. PubMed ID: 25854182
[TBL] [Abstract][Full Text] [Related]
6. Mapping the coevolution, leadership and financing of research on viral vectors, RNAi, CRISPR/Cas9 and other genomic editing technologies.
Fajardo-Ortiz D; Shattuck A; Hornbostel S
PLoS One; 2020; 15(4):e0227593. PubMed ID: 32294089
[TBL] [Abstract][Full Text] [Related]
7. Impact of RNA-guided technologies for target identification and deconvolution.
Fennell M; Xiang Q; Hwang A; Chen C; Huang CH; Chen CC; Pelossof R; Garippa RJ
J Biomol Screen; 2014 Dec; 19(10):1327-37. PubMed ID: 25163683
[TBL] [Abstract][Full Text] [Related]
8. Recent advances in RNAi-based strategies for therapy and prevention of HIV-1/AIDS.
Swamy MN; Wu H; Shankar P
Adv Drug Deliv Rev; 2016 Aug; 103():174-186. PubMed ID: 27013255
[TBL] [Abstract][Full Text] [Related]
9. Partial gene suppression improves identification of cancer vulnerabilities when CRISPR-Cas9 knockout is pan-lethal.
Krill-Burger JM; Dempster JM; Borah AA; Paolella BR; Root DE; Golub TR; Boehm JS; Hahn WC; McFarland JM; Vazquez F; Tsherniak A
Genome Biol; 2023 Aug; 24(1):192. PubMed ID: 37612728
[TBL] [Abstract][Full Text] [Related]
10. Genome-Wide CRISPR Screening for the Identification of Therapy Resistance-Associated Genes in Urothelial Carcinoma.
Mantwill K; Nawroth R
Methods Mol Biol; 2023; 2684():155-165. PubMed ID: 37410233
[TBL] [Abstract][Full Text] [Related]
11. CRISPR-Cas9: A Revolutionary Tool for Cancer Modelling.
Torres-Ruiz R; Rodriguez-Perales S
Int J Mol Sci; 2015 Sep; 16(9):22151-68. PubMed ID: 26389881
[TBL] [Abstract][Full Text] [Related]
12. RNA Interference (RNAi) Screening in
Heigwer F; Port F; Boutros M
Genetics; 2018 Mar; 208(3):853-874. PubMed ID: 29487145
[TBL] [Abstract][Full Text] [Related]
13. Liver Cancer Gene Discovery Using Gene Targeting, Sleeping Beauty, and CRISPR/Cas9.
Kieckhaefer JE; Maina F; Wells RG; Wangensteen KJ
Semin Liver Dis; 2019 May; 39(2):261-274. PubMed ID: 30912094
[TBL] [Abstract][Full Text] [Related]
14. CRISPRi and CRISPRa Screens in Mammalian Cells for Precision Biology and Medicine.
Kampmann M
ACS Chem Biol; 2018 Feb; 13(2):406-416. PubMed ID: 29035510
[TBL] [Abstract][Full Text] [Related]
15. RNA interference: new mechanistic and biochemical insights with application in oral cancer therapy.
Buduru S; Zimta AA; Ciocan C; Braicu C; Dudea D; Irimie AI; Berindan-Neagoe I
Int J Nanomedicine; 2018; 13():3397-3409. PubMed ID: 29922059
[TBL] [Abstract][Full Text] [Related]
16. CircRNA knockdown based on antisense strategies.
Aquino-Jarquin G
Drug Discov Today; 2024 Jun; ():104066. PubMed ID: 38908546
[TBL] [Abstract][Full Text] [Related]
17. The Current Situation and Development Prospect of Whole-Genome Screening.
Yang C; Lei Y; Ren T; Yao M
Int J Mol Sci; 2024 Jan; 25(1):. PubMed ID: 38203828
[TBL] [Abstract][Full Text] [Related]
18. A CRISPR view of gene regulation.
Banerjee B; Sherwood RI
Curr Opin Syst Biol; 2017 Feb; 1():1-8. PubMed ID: 28966990
[TBL] [Abstract][Full Text] [Related]
19. Application of CRISPR/Cas9 Pooled Screening for a Non-immediate Readout Model.
Terzi Çizmecioglu N
Methods Mol Biol; 2024 Mar; ():. PubMed ID: 38441725
[TBL] [Abstract][Full Text] [Related]
20. [GENE THERAPY: FROM TECHNOLOGY TO REALITY].
Galun E
Harefuah; 2024 Feb; 163(2):97-101. PubMed ID: 38431858
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
